Hikal resumes production at Taloja site

29 Oct 2019 Evaluate

Hikal has resumed normal production at Taloja site post the 100% restoration of water by MIDC. Pursuant to the Supreme Court order, MIDC has restored 100% supply of water to the Taloja MIDC zone on October 25, 2019. MIDC had cut 50% of the water supply last quarter which severely affected the operations in Q2 of FY20 resulting in lower production and sales.

Further, the Mahad site which was affected by heavy flooding in Q2FY20 resulting in a loss of production has also resumed normal production.

Hikal is engaged in R&D, manufacturing and marketing of fine chemicals for the Pharmaceutical and Agrochemical industries.

Hikal Share Price

390.75 3.10 (0.80%)
22-Nov-2024 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1797.80
Dr. Reddys Lab 1213.90
Cipla 1486.30
Lupin 2069.95
Zydus Lifesciences 948.70
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.